Source: UniDoc Health.
  • UniDoc Health Corp. (UDOC) has received approval to trade on the US OTCQB Markets under the new symbol UDOCF
  • The company also announced that its common shares are now eligible for electronic clearing and settlement through the DTC
  • DTC eligibility reduces costs and accelerates the settlement process for investors and brokers
  • UniDoc is a virtual health/telemedicine solutions company
  • UniDoc Health Corp. (UDOC) is up 4.17 per cent on the day, trading at C$1.25 per share at 10:15 am EST

UniDoc Health Corp. (UDOC) has received approval to trade on the US OTCQB Markets under the new symbol UDOCF. 

The company also announced that its common shares are now eligible for electronic clearing and settlement through the DTC.

“We are pleased to have obtained DTC eligibility and we view trading on the OTC Market as an important step for UniDoc to reach a broad and diverse audience with our story and to complement our existing investor base,” said Antonio Baldassarre, UniDoc’s President.

“We look forward to building a US investor base and today’s news is an important milestone to strengthen our overall market presence. We expect this will lead to greater liquidity as well as our shares becoming more accessible to a broader range of investors.”

DTC eligibility reduces costs and accelerates the settlement process for investors and brokers allowing its common shares to be traded over a wider selection of brokerage firms.

Existing investors benefit from potentially greater liquidity and faster execution speeds. This also opens the door to new investors that may have been previously restricted from purchasing the company’s common shares and simplifies the process of trading them in the United States.

UniDoc is developing a self-contained remote virtual clinic that mimics a physician’s office. Its target market includes those challenged by access, experience or understanding of online computer technology.

UniDoc Health Corp. (UDOC) is up 4.17 per cent on the day, trading at C$1.25 per share at 10:15 am EST.

More From The Market Online

PharmAla Biotech launches educational portal for MDMA

PharmAla Biotech (CSE:MDMA) launches its Prescribers Portal for medical practitioners to learn more about MDMA.

BlackBerry expands AI-powered cybersecurity service

BlackBerry (TSX:BB) releases the new and expanded CylanceMDR, a managed detection and response tool backed by its Cylance AI platform.

Qualcomm stock jumps on Q2 2024 earnings

Qualcomm (NDAQ:QCOM) shares rise nearly 10 per cent early Thursday on better-than-expected adjusted earnings and strong revenue guidance.

Cancer-fighting pharma stock eyes 2027 regulatory approval

Theralase Technologies (TSXV:TLT), a cancer-fighting pharma stock, expands its team with two clinical research associates.